SD Biotechnologies에스디생명공학
217480 · KOSDAQ · ₩217480 · 에스디생명공학
₩499 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 45.4% | 44.6% | 44.0% | 42.2% | 22.2% | 29.0% |
| Operating margin | −22.5% | −21.0% | −26.8% | −29.1% | −44.2% | −27.9% |
| Net margin | −26.9% | −24.5% | −41.4% | −9.8% | −78.3% | −34.9% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −14.9% | −12.8% | −26.6% | −49.4% | −25.5% | — |
| Operating income growth | +9.1% | +31.5% | +32.3% | +66.7% | −17.8% | — |
| Net income growth | +6.4% | +48.4% | −209.8% | +93.7% | −67.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −24.4% | −25.2% | −39.0% | −19.6% | −296.6% | −94.8% |
| Return on assets | −17.4% | −13.8% | −21.6% | −7.0% | −61.7% | −30.8% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 15.9% | 60.5% | 103.7% | 68.8% | 1,897.5% | 199.1% |
| Net debt to equity | −13.4% | 27.3% | −11.6% | −43.1% | 731.7% | 60.8% |
| Current ratio | 855.3% | 248.7% | 148.5% | 191.3% | 56.6% | 94.9% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: SD Biotechnologies / 에스디생명공학 / 217480 / KRX:217480
Source: KRX statistical information